168 related articles for article (PubMed ID: 27515268)
21. Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.
Wiese DA; Thaiwong T; Yuzbasiyan-Gurkan V; Kiupel M
BMC Cancer; 2013 Sep; 13():403. PubMed ID: 24004841
[TBL] [Abstract][Full Text] [Related]
22. Functional comparison of the human epidermal growth factor receptor and telomerase reverse transcriptase promoters in canine tumor cells.
Okamoto M; Soeda T; Asamura A; Tanaka K; Watanabe K; Ikeda T
J Vet Med Sci; 2019 Mar; 81(3):397-400. PubMed ID: 30674742
[TBL] [Abstract][Full Text] [Related]
23. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.
Izadi P; Mehrdad N; Foruzandeh F; Reza NM
Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526
[TBL] [Abstract][Full Text] [Related]
24. Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens.
de Cremoux P; Tran-Perennou C; Brockdorff BL; Boudou E; Brünner N; Magdelénat H; Lykkesfeldt AE
Endocr Relat Cancer; 2003 Sep; 10(3):409-18. PubMed ID: 14503918
[TBL] [Abstract][Full Text] [Related]
25. The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium.
Rokicki J; Das PM; Giltnane JM; Wansbury O; Rimm DL; Howard BA; Jones FE
Mol Cancer; 2010 Jun; 9():150. PubMed ID: 20550710
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
27. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues.
Donnay I; Rauïs J; Wouters-Ballman P; Devleeschouwer N; Leclercq G; Verstegen JP
J Reprod Fertil Suppl; 1993; 47():501-12. PubMed ID: 8229969
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.
Prat A; Parker JS; Karginova O; Fan C; Livasy C; Herschkowitz JI; He X; Perou CM
Breast Cancer Res; 2010; 12(5):R68. PubMed ID: 20813035
[TBL] [Abstract][Full Text] [Related]
29. Expression patterns of the erbB subfamily mRNA in canine benign and malignant mammary tumors.
Matsuyama S; Nakamura M; Yonezawa K; Shimada T; Ohashi F; Takamori Y; Kubo K
J Vet Med Sci; 2001 Sep; 63(9):949-54. PubMed ID: 11642281
[TBL] [Abstract][Full Text] [Related]
30. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.
Tamimi RM; Baer HJ; Marotti J; Galan M; Galaburda L; Fu Y; Deitz AC; Connolly JL; Schnitt SJ; Colditz GA; Collins LC
Breast Cancer Res; 2008; 10(4):R67. PubMed ID: 18681955
[TBL] [Abstract][Full Text] [Related]
31. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
Burga LN; Hu H; Juvekar A; Tung NM; Troyan SL; Hofstatter EW; Wulf GM
Breast Cancer Res; 2011 Mar; 13(2):R30. PubMed ID: 21396117
[TBL] [Abstract][Full Text] [Related]
32. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
33. Inner nuclear membrane localization of epidermal growth factor receptor (EGFR) in spontaneous canine model of invasive micropapillary carcinoma of the mammary gland.
Rodrigues MA; Gamba CO; Faria JA; Ferreira Ê; Goes AM; Gomes DA; Cassali GD
Pathol Res Pract; 2016 Apr; 212(4):340-4. PubMed ID: 26944829
[TBL] [Abstract][Full Text] [Related]
34. Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas.
Maniscalco L; Millán Y; Iussich S; Denina M; Sánchez-Céspedes R; Gattino F; Biolatti B; Sasaki N; Nakagawa T; Di Renzo MF; de Las Mulas JM; De Maria R
BMC Vet Res; 2013 Apr; 9():80. PubMed ID: 23587222
[TBL] [Abstract][Full Text] [Related]
35. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
36. Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.
Skarlos P; Christodoulou C; Kalogeras KT; Eleftheraki AG; Bobos M; Batistatou A; Valavanis C; Tzaida O; Timotheadou E; Kronenwett R; Wirtz RM; Kostopoulos I; Televantou D; Koutselini E; Papaspirou I; Papadimitriou CA; Pectasides D; Gogas H; Aravantinos G; Pavlidis N; Arapantoni P; Skarlos DV; Fountzilas G
Cancer Chemother Pharmacol; 2012 Feb; 69(2):533-46. PubMed ID: 21901395
[TBL] [Abstract][Full Text] [Related]
37. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
[TBL] [Abstract][Full Text] [Related]
38. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
Mainenti M; Rasotto R; Carnier P; Zappulli V
Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
[TBL] [Abstract][Full Text] [Related]
39. Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications.
Chen C; Yuan JP; Wei W; Tu Y; Yao F; Yang XQ; Sun JZ; Sun SR; Li Y
Int J Nanomedicine; 2014; 9():1039-48. PubMed ID: 24591826
[TBL] [Abstract][Full Text] [Related]
40. Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.
Zhang C; Mori M; Gao S; Li A; Hoshino I; Aupperlee MD; Haslam SZ; Xiao H
Cancer Res; 2010 Dec; 70(24):10224-33. PubMed ID: 21159643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
